Survey Release: Employee Perceptions of GLP-1 Medications

Employers are making high-stakes GLP-1 coverage decisions based on market headlines, not employee reality. Goodpath surveyed 1,049 employees to close that gap.

The data shows that 97% of employees are aware of GLP-1 medications. But awareness isn't the same as readiness, and demand isn't the same as well-managed utilization.

Without thoughtful benefit design, employees pursue GLP-1s on their own, often without clinical oversight, wraparound support, or long-term planning.

This report gives benefits leaders and consultants the employee-level data needed to design coverage that balances access, cost management, and sustainable outcomes.

Download the full report to see what your workforce is already thinking.